GSK reported positive survival data for Blenrep combined with bortezomib and dexamethasone in multiple myeloma DREAMM-7 trial, outperforming daratumumab combination therapy. GSK plans US relaunch in ...
There is a link on our Facebook page that you can share and you can also find the link it in our instagram bio until the ...